"Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A ..."

Anna Erol et al. (2025)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2025.110471

access: closed

type: Journal Article

metadata version: 2025-06-25

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/ErolCZSOSDSRTMKSGRKMKN25
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/ErolCZSOSDSRTMKSGRKMKN25
Anna Erol, Karolina Chwialkowska, Anna Zeller, Anna Skwarska, Agnieszka Ostrowska, Gabriela Sokolowska, Katarzyna Doroszko, Iwona Sidorkiewicz, Justyna Raczkowska, Damian Toczydlowski, Anna Michalska-Falkowska, Mariusz Kuzmicki, Jacek Szamatowicz, Joanna Gielazyn-Reszec, Michal Ryn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski, Magdalena Niemira:
Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approach. Comput. Biol. Medicine 194: 110471 (2025)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.